Skip to main content
Clinical Trials/NCT04728113
NCT04728113
Completed
Not Applicable

Early Integration of Supportive Care Into Standard Oncology Care for Metastatic Uveal Melanoma Patients

Institut Curie2 sites in 1 country162 target enrollmentJuly 16, 2020
ConditionsUveal Melanoma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Uveal Melanoma
Sponsor
Institut Curie
Enrollment
162
Locations
2
Primary Endpoint
34 items - Supportive Care Needs Survey
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

The study main objective is to assess whether the early introduction of supportive care demonstrates a benefit on patients' psychological care needs at 6 months (M6), versus oncological standard of care in patients with metastatic UM.

Supportive care in patients with metastatic Uveal Melanoma (UM)

Detailed Description

Before the start of the study, medical oncologists and supportive care physicians from both the sites will attend Communication Skills Training (CST) workshops provided by an expert team in the field. The training sessions will focus on practicing the required communication skills needed in consultations. The randomization will assign patients, with a 1:2 ratio, to "Introduction of supportive care when medically needed" (Arm A: Control Group) or "Initial concomitant management by the oncologist and the supportive care team" (Arm B: Early Together Group). Selected and validated questionnaires will be filled at baseline, 6 and 12 months by the patients before the consultation, in the 2 groups.

Registry
clinicaltrials.gov
Start Date
July 16, 2020
End Date
January 22, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • adult patients with metastatic UM;
  • no surgery or loco-regional treatment of metastases in a curative intent;
  • systemic treatment planned or started since less than 2 months;
  • ECOG PS 0-1;
  • no uncontrolled symptoms;
  • liver function tests in normal range or ≤ grade 2;
  • signed informed consent;
  • able to fill the questionnaires.

Exclusion Criteria

  • patient\<18 years old;
  • patient condition requiring supportive care before any systemic specific treatment for metastases;
  • acute psychopathological disorder incompatible with the study;
  • prior medical condition incompatible with the study.

Outcomes

Primary Outcomes

34 items - Supportive Care Needs Survey

Time Frame: 6 months

The main study criterion is the score to the "Care and Support Needs" domain (items 18-22) of the SCNS-SF34 questionnaire obtained in the two arms at 6 months after inclusion. A 10 points mean score difference expected between groups. Each question is ranged from 0 (no need of supportive care) to 5 (strong need of supportive care). Scores for Outcome 1 may vary from 0 to 25.

Study Sites (2)

Loading locations...

Similar Trials